Aker BioMarine suffers net loss in Q4
Published on
February 22, 2022
Aker BioMarine ASA achieved revenue of USD 75.7 million (EUR 66.6 million) and adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) of USD 7.2 million (EUR 6.3 million) in the fourth quarter of 2021, compared with USD 75.5 million (EUR 66.4 million) and USD 21.1 million (EUR 18.6 million) in the corresponding period of 2020 ...
Photo courtesy of Aker BioMarine
Share